Modern healthcare is being asked to do something it was never built to do: keep people healthy, not just treat them once they fall sick. Many countries have tried to transition from illness treatment to prevention, but progress has frequently been hindered by fragmented systems, legacy infrastructure, and intricate regulatory frameworks. However, across the Gulf region, there lies a unique opportunity to design healthcare systems that inherently incorporate prevention, personalization, and data-driven decision making from the outset. Healthcare leaders are increasingly recognizing that a reactive approach to medicine is economically unsustainable and clinically outdated, particularly as populations of age and chronic diseases become more prevalent. The challenge extends beyond merely constructing more hospitals or expanding existing care models. It demands the creation of a healthcare architecture capable of predicting risk, intervening early, and enhancing long-term well-being. Saudi Arabia and the broader Gulf region are well-positioned to lead this transformative transition. Significant investments in digital infrastructure, research, and innovation present an opportunity to build health systems that focus on keeping people healthy, rather than simply treating illness. By integrating artificial intelligence, genomics, and advanced analytics, the region can play a pivotal role in shaping the next generation of healthcare. A crucial consideration lies in the role of local data. Numerous genomic datasets and medical AI models have been developed predominantly using Western populations. Consequently, the genetic markers, lifestyle variables, and metabolic baselines employed in these systems may not fully align with Middle Eastern populations. Therefore, building smart health solutions utilizing local genomic and clinical data will be indispensable to ensuring accurate diagnoses, effective treatments, and meaningful prevention strategies. At the KAUST Center of Excellence for Smart Health, our research focuses on unraveling the molecular mechanisms that drive disease and aging within local populations. One area of particular interest is “inflammaging,” a chronic, low-grade inflammation linked to age-related conditions like diabetes, neurodegeneration, and muscle loss. By integrating genomics, molecular biology, and AI-driven analysis, researchers can identify risk factors earlier and develop targeted interventions before symptoms escalate. This is precision medicine at its core. Instead of managing chronic diseases after they manifest, precision genomics enables early intervention based on an individual’s unique biological profile. The ultimate objective is to extend a health span, the years of life lived in good health, and bring it closer to an overall lifespan. In doing so, healthier populations can reduce healthcare costs, remain economically active for longer, and contribute to broader national prosperity. But technology and data alone won’t be enough. Success hinges on human capital. The region needs professionals who can work across disciplines, fluent in medicine, biology, data science, and artificial intelligence at once. Building this talent requires initiatives that connect universities, research centers, hospitals, and industry. That ambition is already taking concrete form at KAUST. With Alfaisal University, we co-founded the first MD-Ph.D. program in Saudi Arabia and the region, welcoming its first cohort in 2022 to train physician-scientists who bring AI and precision medicine straight to the bedside. And we are working hand in hand with the Kingdom’s leading medical institutions to turn laboratory discoveries into better diagnosis, treatment, and, above all, prevention. These partnerships are the bridge between research and real patient care. Examples are already emerging. Research institutions like KAUST are pioneering interdisciplinary health science programs, while national digital transformation initiatives are creating new avenues for collaboration between clinicians, computational biologists, and AI specialists. Together these efforts build the local capability needed to develop, deploy, and scale precision-health solutions. The global race to shape the future of medicine is no longer confined to traditional healthcare hubs. By learning from the limits of legacy systems and investing in local, data-driven innovation, Saudi Arabia and the Gulf can emerge as leaders in preventative and precision medicine. The ambition goes beyond building a digital economy; it’s about safeguarding the biological foundation of future generations through longer, healthier lives. Imed Gallouzi is professor of bioscience and associate dean of the BioMed Division, as well as chair of the KAUST Center of Excellence for Smart Health.